skip to Main Content
Sheppard Mullin Launches Cannabis Industry Team


Cross-practice Group Brings Together Firmwide Experience to Support the Fast-Growing Cannabis Industry

LOS ANGELES, June 4, 2019 — Sheppard, Mullin, Richter & Hampton LLP is pleased to announce the launch of a new Cannabis Industry Team.  Currently, the team is comprised of more than 70 attorneys from 12 of the firm’s offices. 

“With worldwide legal cannabis spending at more than $12 billion in 2018 and projected to grow to almost $17 billion in 2019, now more than ever cannabis industry businesses need good, sound, experienced legal advice,” said Sheppard Mullin partner Whitney Hodges, leader of the firm’s Cannabis Industry Team. “Sheppard Mullin’s Cannabis Industry Team provides a one-stop shop for clients and is ready to tackle even the most daunting challenges our cannabis clients face.  Our team monitors notable industry trends and legislative developments to provide timely guidance to clients seeking to navigate the maze of often-conflicting federal, state and local laws and regulations governing cannabis.” 

Added Sheppard Mullin managing partner Robert Beall, “Two-thirds of the states and the District of Columbia now permit recreational or medical cannabis use in some form, so cannabis businesses often have trouble finding well-versed lawyers with mainstream law firms to represent them.  Our breadth and depth of experience makes us ideally poised to fill that void.”

Some of Sheppard Mullin’s cannabis industry clients include MassRoots, JoshD Farms, Uniqorn Capital Investments, Mextraction LLC, and Cannelure Partners LLC. The firm currently has more than 40 active clients in the cannabis industry. 

About Sheppard Mullin’s Cannabis Industry Team

Sheppard Mullin’s Cannabis team, led by San Diego partner Whitney Hodges and Los Angeles associate Sarah Blitz, helps cannabis and ancillary businesses, including hemp CBD-based or infused products companies, with a wide array of issues attendant to legal cannabis business activities, including regulatory compliance, raising and deploying capital, banking and finance, accounting control and anti-money laundering compliance, real estate development and leasing, litigation, intellectual property, public company representation and SEC filings, land use and zoning, investigations and taxation.  In addition to advising participants in the medical and adult-use marijuana industries, as the industry has grown, Sheppard Mullin attorneys experienced in cannabis-related issues frequently advise clients in other sectors whose businesses intersect with the cannabis industry, including real estate development, banking and financing, insurance and employment.

About Sheppard, Mullin, Richter & Hampton LLP

Sheppard Mullin is a full-service Global 100 firm with more than 850 attorneys in 15 offices located in the United States, Europe and Asia. Since 1927, industry-leading companies have turned to Sheppard Mullin to handle corporate and technology matters, high-stakes litigation and complex financial transactions.  In the U.S., the firm’s clients include more than half of the Fortune 100.  For more information, please visit


This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Texas says popular cannabis extract, delta-8, is illegal, sending retailers scrambling

The federal farm bill in 2018 made the substance legal because of its low THC content. Three years after federal legislation removed the marijuana extract known as delta-8 THC from the nation’s list of controlled substances, Texas health officials have put it on its own list of illegal drugs, sending a shockwave through the growing…

The Cannabis Industry is Rife with Fraudsters. The FDA is AWOL.

The FDA’s failure to regulate a multibillion-dollar market is a detriment to consumers and businesses alike. In August of last year, the Food and Drug Administration held a teleconference with Sarah Brown, the proprietor of Maison Terre, a natural products repackager that Brown ran out of her home in Arkansas. An FDA lab analysis had…

Plop-Plop, Fiz-Fiz Oh What a Relief It Is, MJBizCon is Back!

In my 40 years of collecting a paycheck, I gotta admit this has been the oddest business trip I have ever embarked on, beginning with the packed Spirit Airline flight from Baltimore-Washington International Airport to the check-in at the Westgate hotel to grabbing my press credentials Tuesday afternoon at the Las Vegas Convention Center. When…

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by around 50 members. The meeting in Arlington St, next to the Ritz Hotel, London, saw members consider part-funding a university-based cost benefit analysis into the efficacy of the medical cannabis. A second proposed work stream aims…

More Categories

Back To Top
×Close search